Surgical Oncologist, Brigham and Women's/Mass General Brigham. Pancreas, Liver, Biliary, and upper GI surgery. Dad. Husband. Sox fan.
Joined February 2013
- Tweets361
- Following578
- Followers1.2K
- Likes1.2K
Thomas Clancy retweeted
It takes decades to build the momentum in science — now is the time — at the pioneering edge of almost every scientific field — to sustain it!! @MGBResearchNews #NumberOne 🧠 🔬 🧫 🧬
nature.com/nature-index/rese…
Thomas Clancy retweeted
Can we restrain, reverse, or eliminate pancreatic precancers before they become invasive? Following #AACRpan26, @Aiims1742 @BenStanger01 @MadameSurgeon and I discuss hopes for #PancreaticCancer interception in @Nature.
nature.com/articles/d41586-0…
Thomas Clancy retweeted
New paper from Stephanie Dougan @DanaFarber_Hale with @NobelPrize David Baker in @CellCellPress!
CD4 T cells convert transient responses to KRAS inhibition to durable remissions in #PancreaticCancer
cell.com/cell/fulltext/S0092…
Synthetic cytokines for the win!
#AACRPan26
We are excited to announce the inaugural Mass General Brigham Cancer Instititute Pancreatic Cancer Symposium on Nov 18. We will highlight some of the most innovative work in this disease happening across our system. Honored to have keynote lecture by Dr Liz Jaffee.
So proud to be part of this team!
instagram.com/reel/DZVxYgGAY…
Check out Thomas Clancy's fundraising page - fundraise.massgeneralbrigham…
Last push before BAA 10K to support our hepatopancreatobiliary program at Mass General Brigham Cancer Institute
Thomas Clancy retweeted
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM
@ASCO
ALT Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.
Thomas Clancy retweeted
Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer
Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived
#ASCO26
Thomas Clancy retweeted
Absolutely practice changing!! One of the most stunning developments in the treatment of patients with metastatic pancreatic cancer !! It is one of the rare moments in oncology which you will always remember ! Like the imatinib, trastuzumab presentations @ASCO #ASCO26 @OncoAlert
Thomas Clancy retweeted
I hope you didn’t miss out on @paul_wongg talk at #AHPBA26 on an externalized pancreatic stent during robotic Whipple!! Looking forward to the manuscript! 💫
You look GREAT!
@TClancyMD told me in November, two weeks post Whipple that I would enjoy a walk on the beach in March and not feel the effects of the surgery.
I doubted him.
Today I took that walk and he was right. I didn’t feel the effects of the surgery.
I even stopped to capture an image of the moment.
Praise God and thank you Dr. Clancy.
Thomas Clancy retweeted
Excellent review👏by @shimulshah73 & team
#transplantoncology #cholangiocarcinoma
It is great to see how prior therapies evolve in
the developing landscape of drug discovery.
Now need to find optimal treatment sequence
so as to not🔥🌉maybe with🧬profile
@OHSUKnight @curecc
February is Gallbladder & Bile Duct Awareness Month!
New JOGS Article “Liver transplant for intrahepatic cholangiocarcinoma: current evidence & clinical practice recommendations” out now!
Congrats @RoiAnteby, @benvierra95, & @shimulshah73.
Read more: ow.ly/s2RS50Yi8sl
Thomas Clancy retweeted
Honored to be part of this team and a great 2025…200 lives saved so far with liver transplants. @MGHSurgery @ASTSChimera
Thomas Clancy retweeted
Our MSK HPB symposium is just one week away! Join us in NYC to learn and discuss the latest advances in mCRC and pancreas cancer. Register here: bit.ly/MSKHPB2025 @EileenMOReilly @MSKCME @BasGrootKoerkam @michael_lidsky @MichaelDAngeli2 @surgeonweiss @HopSTranCao
Thomas Clancy retweeted
Just one month away! Join us in NYC on Nov 20-21 for the MSK HPB Symposium, featuring the latest advances in mCRC and pancreas cancer. Register here: bit.ly/MSKHPB2025 @EileenMOReilly @MSKCME @BasGrootKoerkam @MichaelDAngeli2 @michael_lidsky
Thomas Clancy retweeted
The team at Mass General Brigham has the most cancer specialists in New England, bringing more hope to patients every day.
Thomas Clancy retweeted
Looking forward to a new position as Director of Interventional Cardiology at Mass General Brigham. With incredible colleagues throughout the system, we will build the most comprehensive IC program internationally.
Thomas Clancy retweeted
Recent work by our lab showing feasibility as a biomarker in pancreas cancer #ctDNA #Chawlalab @MPishvaian @PatricioPolanc0 @TheNotoriousHPB @SyedAAhmad5 @skmaithel @EileenMOReilly @NMSurgery @LurieCancer
Tumor-agnostic ctDNA NGS was feasible in localized pancreatic cancer and captured dynamic treatment response. ctDNA absence tracked with CA19-9 drop and better outcomes.
journals.lww.com/annalsofsur…
Thomas Clancy retweeted
Congrats to the GGI team for an fun BWH #Boston10K that raised money for pancreatic cancer research! Sweats, grazes and muscle cramps to show for our efforts!
@BrighamWomens @BrighamSurgery @BAA
Thomas Clancy retweeted
“No children are dying on my watch,” said Rubio. It's blatantly false. Credible estimates count 190K deaths so far.
In Kenya, I am documenting for a film devastating impact, including this child's starvation & many deaths directly caused by Rubio’s actions. See my @msnbc clip
